Vermillion Wealth Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Vermillion Wealth Management’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50	Closed	-$40	–	2278
2026 Q1	$40	Hold	50	–	–	﹤0.01%	1507
2025 Q4	$279	Buy	+50	New	+$556	﹤0.01%	585

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Vermillion Wealth Management's RVPH Position: Q2 2026 in Review

Vermillion Wealth Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 50 shares — an estimated $40 sold.

Vermillion Wealth Management first reported a position in RVPH in Q4 2025 and held it in 2 quarters. The position peaked at $279 in Q4 2025. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Vermillion Wealth Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Vermillion Wealth Management sold 50 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $40.
Vermillion Wealth Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2025 and held it in 2 quarters.
Vermillion Wealth Management's REVIVA PHARMA HLDGS INC position peaked at $279 in Q4 2025.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.